-
Medtronic spine's 'winning formula'
On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff Martha credited one of the company's key product lines for spine growth in an Aug. 20 earnings call. -
Medtronic nets $1B net income in Q1
Medtronic posted $7.9 billion in sales for the first quarter of fiscal year 2025, according to an Aug. 20 news release. -
Multiple law firms to investigate Globus Medical following FDA warning
At least four law firms have launched investigations into Globus Medical after the company received a warning letter from the FDA. -
Patent verdict supporting Globus Medical upheld
A judge has upheld a 2023 patent infringement verdict in favor of Globus Medical, according to Aug. 13 court documents filed in the U.S. District Court for the Eastern District of Pennsylvania. -
4 medtech notes: Stryker, DePuy Synthes and more
From new acquisitions to FDA clearances, here are four updates from orthopedic devicemakers since Aug. 7. -
Stryker to acquire AI company
Stryker signed a definitive agreement to acquire care.ai, a company developing artificial intelligence-assisted virtual care workflows and smart room technology. -
More payers bolster spine coverage: 6 things to know
From implants to surgical techniques, national and commercial payers are updating their policies to expand access to spine care. -
Stryker vs. Zimmer Biomet vs. J&J in Q2: How 3 spine companies compare
Stryker, Johnson & Johnson and Zimmer Biomet posted their second-quarter financial results for 2024 and data on their spine orthopedic sales. -
Stryker, Orthofix and more: 8 medtech notes
From financial updates to new Medicare policy, here are eight key updates from spine and orthopedic devicemakers since July 24. -
Globus Medical's Q2 sales increase 115.9%: 5 notes
Globus Medical saw net sales of $629.7 million in the second quarter, according to financial results posted Aug. 7. -
Orthofix to push 7D Flash navigation into ASCs
The next step for Orthofix's 7D Flash navigation for spine is outpatient, CEO Massimo Calafiore said in an Aug. 6 earnings call. -
Alphatec directors buy more company stock
Two Alphatec executives acquired more shares of company stock, according to Aug. 5 Securities and Exchange Commission filings. -
2 spine devicemakers raise millions
Two spine medtech companies secured financing to support their growth. -
Orthofix reports 6% sales growth, $33.4M net loss in Q2
Orthofix saw second quarter sales rise year-over-year in the second quarter of 2024, according to financial results posted Aug. 6. -
Neuralink implanted in 2nd patient
A second patient received a Neuralink implant, USA Today reported Aug. 5. -
Personalized spine implants get CMS coverage
Carlsmed's aprevo spine implants earned favorable payment coverage from Medicare, the devicemaker said Aug. 5. -
MiRus spine device earns breakthrough designation
MiRus earned the FDA's breakthrough device designation for the Europa posterior cervical system, the devicemaker said July 31. -
Alphatec sees 25% revenue growth, $41M net loss in Q2
Alphatec reported second quarter revenue of $146 million, according to financial results shared July 31. -
Camber Spine earns FDA nod for SPIRA-A device
Camber Spine earned FDA 510(k) approval for its Spira-A integrated fixation system. -
Stryker's orthopedic sales rise 8.5% in Q2: 6 notes
Stryker saw an 8.5% year-over-year increase in net sales during the second quarter of 2024, according to financial results posted July 30.
Page 5 of 200